Application Deadline: May 17, 2026
The LEAD Model Request for Applications was released March 31, 2026. ACOs accepted under this RFA will begin participation January 1, 2027. The window to evaluate, prepare, and apply is short. If you're considering LEAD, the time to act is now — not after the deadline passes.


How We Got Here — A Program That Kept Learning

The Medicare Shared Savings Program launched in 2013 with a simple premise: bring physicians and hospitals together into Accountable Care Organizations, hold them accountable for both the quality and cost of care for their attributed Medicare population, and share in the savings when they succeed. That premise has proven durable. Twelve years of MSSP data shows a program that matured significantly — from 23.6% of ACOs earning savings in 2013 to 75.4% in 2024, generating $4.1 billion in shared savings in a single year.

But MSSP was built for a different era of value-based care — one where the primary challenge was simply getting providers into risk-based arrangements at all. Over time, its limitations became clear. The three-year rebasing cycle penalized ACOs that performed too well by raising their benchmarks. High-needs populations were inadequately captured by prospective risk adjustment. Smaller and rural providers lacked the scale and infrastructure to participate meaningfully. And the program's relatively short agreement periods didn't give organizations enough runway to fully realize the return on their VBC investments.

The Innovation Center responded. ACO REACH introduced stronger financial incentives, capitated payments, and better high-needs risk adjustment. It expanded participation beyond traditional provider structures. It brought in health equity as an explicit program goal. It learned. And now, building on everything MSSP and ACO REACH taught about what works and what doesn't, CMS has announced its most ambitious accountable care model to date.

The Long-term Enhanced ACO Design — LEAD — isn't just another iteration. It represents a genuine rethinking of what a durable, sustainable, inclusive accountable care program can look like.


What Is LEAD?

LEAD is a voluntary, total cost of care ACO model launching January 1, 2027, following the conclusion of ACO REACH at the end of 2026. It will run for ten years — through December 31, 2036 — making it the longest performance period CMS has ever tested in any innovation model.

10
Year performance period — the longest CMS has ever tested
45%
Of Original Medicare beneficiaries currently aligned to an ACO — LEAD aims to expand that significantly
May 17
2026 application deadline for PY 2027 participation

The model is designed to serve a broader mix of providers than previous Innovation Center models — explicitly including organizations new to ACOs, smaller and independent practices, rural providers, and organizations that disproportionately serve complex, high-needs, or dually eligible populations. This isn't window dressing: the program's financial architecture is specifically designed to make participation viable for these organizations in ways that MSSP and ACO REACH were not.

CMS's own data provides the rationale: as of January 2026, only 45% of Original Medicare beneficiaries are aligned to the Shared Savings Program or ACO REACH. Previous analyses show that providers not participating in ACOs exhibit higher per-beneficiary spend. Expanding participation isn't just a policy goal — it's where the Medicare savings potential is concentrated.


What Makes LEAD Different

Feature 01
10-Year Benchmark Stability — No Rebasing
LEAD offers a full ten-year performance period with no traditional rebasing. ACOs will not have their benchmarks reset based on their own spending history. This directly addresses one of the most significant structural barriers to sustained MSSP performance: the perverse incentive to avoid generating savings that would raise future benchmarks. Organizations that invest in care transformation early will benefit from a stable reference point for the life of the program.
Feature 02
Concurrent Risk Adjustment for High-Needs Patients
First tested in ACO REACH, concurrent risk adjustment incorporates diagnoses documented during the current performance year rather than relying solely on prior-year data. For high-needs beneficiaries — who often experience rapid changes in health status — this produces significantly more accurate risk scores. ACOs serving complex populations have long been disadvantaged by prospective-only models. LEAD corrects this for all beneficiaries who meet the High Needs criteria, not just those in specialized programs.
Feature 03
Beneficiary Engagement Incentives
LEAD significantly expands the tools ACOs have to drive patient engagement. These include Part B cost-sharing support; Part D premium buy-down (beginning 2029); expanded Medical Nutrition Therapy beyond diabetes and renal disease; and chronic disease prevention rewards — allowing ACOs to offer healthy food products to patients engaged in chronic disease prevention activities. These aren't peripheral benefits — they're the financial tools that enable the proactive engagement strategies that drive performance.
Feature 04
AI-Informed Risk Adjustment Testing Beginning 2028
Starting in 2028, LEAD will begin testing an AI-inferred risk adjustment model, with AI-only risk scores applying to aged and disabled populations beginning in 2031. This is an area worth watching carefully. The healthcare industry's documentation practices and data standardization are still maturing — and an AI model is only as accurate as the data it's trained on. That said, LEAD participation gives organizations a front-row seat to inform how this model evolves. Early participants will be best positioned to contribute real-world performance data and advocate for a methodology that accurately captures the complexity of their populations.
Feature 05
CMS-Administered Risk Arrangements (CARA)
LEAD introduces CARA — a digital data-sharing and payment system that facilitates episode-based risk arrangements between ACOs and specialist providers. This includes a dedicated episode-based falls prevention program and standardized contracting frameworks. CARA enables ACOs to build more robust preferred provider relationships and extend accountability across the care continuum — including a specific focus on high-risk areas like post-acute and specialty care.
Feature 06
Medicare-Medicaid Integration
LEAD will select two states to develop a framework for ACO-Medicaid partnership arrangements, with the goal of better integrating Medicare and Medicaid services for dually eligible beneficiaries. For ACOs serving significant dual populations — who often face fragmented, poorly coordinated care across both programs — this integration component addresses one of the most consequential gaps in the current system.


Choosing Your Path

LEAD offers two voluntary risk-sharing options. The right choice depends on your organization's financial position, care management maturity, and appetite for accountability. Both options use mandatory capitation — ACOs receive set payments rather than payment per claim, a fundamental shift from traditional billing models.

Option Savings Shared Loss Exposure Best For Additional Access
Professional Risk Up to 50% Up to 50% Organizations newer to full risk; those building care management infrastructure Core LEAD benefits and beneficiary engagement tools
Global Risk Up to 100% Up to 100% Mature VBC organizations with established care management and data capabilities Full CARA episode-based arrangements; additional benefit enhancement options

The Global option's access to CARA is significant for organizations ready to extend their accountability framework to specialist care — it creates the infrastructure for preferred provider relationships that can meaningfully reduce downstream costs in high-expense categories like post-acute care, orthopedics, and cardiology.


Who Should Seriously Consider LEAD

Free Tool
Explore the ACO REACH Data Behind This Analysis

The ACO REACH → LEAD Explorer is a free, interactive analytics platform covering all three performance years of ACO REACH (PY2021–2023). Search any of the 150 participating ACOs, explore their savings rate trajectory, quality scores, capitation payment breakdown, and get a personalized LEAD Model transition guide based on their actual performance.

Launch the ACO REACH → LEAD Explorer →

Current ACO REACH participants are the most natural candidates. LEAD is explicitly designed as ACO REACH's successor, and the transition pathway is as direct as CMS has made any model transition. For organizations that have invested in the infrastructure, culture, and clinical workflows to succeed in ACO REACH, LEAD offers a longer runway to realize that investment's return — without the disruption of re-entering a different program.

High-performing MSSP ACOs who have felt the sting of rebasing should look carefully at LEAD's ten-year, no-rebase structure. If your organization has consistently generated savings — and watched your benchmark rise in response — LEAD's stable benchmark offers a fundamentally different value proposition. The data shows that ACOs with 10+ years of experience average 5.20% savings rates. A stable benchmark lets that performance compound over time rather than being reset.

Providers new to ACOs — particularly smaller, independent, and rural practices — are an explicit focus of LEAD's design. The lower alignment minimums for high-needs ACOs, the add-on payments for rural and smaller providers, and the phased risk on-ramps make LEAD more accessible than previous Innovation Center models for organizations that have historically been priced out of meaningful VBC participation.

Organizations serving complex populations — high proportions of dual-eligible beneficiaries, homebound patients, or patients with significant chronic disease burden — will find that LEAD's concurrent risk adjustment, High Needs benchmarking, and Medicare-Medicaid integration work are specifically designed for their populations. The model doesn't require these organizations to fit their patients into a framework built for average Medicare beneficiaries.

LEAD is CMS making an explicit bet that the future of Medicare cost control runs through long-term, stable, inclusive accountable care relationships — not through short-term payment adjustments. For organizations ready to make that bet alongside CMS, the terms have never been better.


Key Dates and Next Steps

Dec 18, 2025
CMS announces LEAD Model — model design, key features, and program goals released publicly
Mar 31, 2026
Request for Applications (RFA) released — detailed application requirements, eligibility criteria, and scoring domains published
May 17, 2026
Application deadline — all applications for PY 2027 participation must be submitted by Eastern Time close of business
Jan 1, 2027
LEAD Model launches — Performance Year 2027 begins; ACO REACH concludes at end of 2026
2028
AI-inferred risk adjustment model testing begins; CARA episode-based arrangements fully operational
2029
Part D premium buy-down benefit enhancement available — ACOs can partially or fully offset beneficiary Part D premiums
2031
AI-only risk scores apply fully to aged and disabled populations — transition to next-generation risk adjustment complete
Dec 31, 2036
LEAD Model performance period concludes — a full decade of accountable care with stable benchmarks

Evaluating LEAD for Your Organization?

The application scoring criteria spans five domains: organizational readiness, revenue sources and payment arrangements, beneficiary and caregiver experience, data and health information, and preventive care. The window is short. We help ACOs and provider organizations assess their fit, model their financial scenarios under Professional vs. Global risk, and prepare competitive applications.

Our team has hands-on experience across MSSP, ACO REACH, and Medicare Advantage value-based arrangements — and we've been tracking LEAD since its announcement. Whether you're a current ACO REACH participant navigating the transition, an MSSP ACO evaluating whether to add LEAD, or a provider organization exploring accountable care for the first time, reach out. The analysis is worth doing now.